ASTEX PHARMACEUTICALS, INC Deferred Tax Assets, Net of Valuation Allowance

ASTEX PHARMACEUTICALS, INC Deferred Tax Assets, Net of Valuation Allowance

ASTEX PHARMACEUTICALS, INC had Deferred Tax Assets, Net of Valuation Allowance of $9.76 million as of 2012-12-31, per its 10-K filed 2013-03-18.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsNet · last filed 2013-03-18

• 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.76M.
• 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance $10.61M.